| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mycobacterium | 10 | 2018 | 143 | 4.07 | Why? |
| Mycobacterium tuberculosis | 16 | 2019 | 1164 | 3.97 | Why? |
| Methanobrevibacter | 8 | 2019 | 15 | 3.42 | Why? |
| Yersinia pestis | 6 | 2018 | 58 | 3.04 | Why? |
| Plague | 6 | 2018 | 155 | 2.91 | Why? |
| Tuberculosis, Pulmonary | 9 | 2019 | 1171 | 2.52 | Why? |
| Mycobacterium ulcerans | 4 | 2017 | 15 | 2.30 | Why? |
| Nontuberculous Mycobacteria | 5 | 2018 | 114 | 2.24 | Why? |
| Bacteriological Techniques | 6 | 2019 | 239 | 2.18 | Why? |
| Planctomycetales | 3 | 2018 | 4 | 2.05 | Why? |
| Mycobacterium bovis | 4 | 2018 | 125 | 2.02 | Why? |
| DNA, Bacterial | 14 | 2018 | 835 | 1.90 | Why? |
| Antitubercular Agents | 7 | 2019 | 775 | 1.77 | Why? |
| Tuberculosis, Multidrug-Resistant | 5 | 2019 | 433 | 1.74 | Why? |
| Buruli Ulcer | 3 | 2017 | 17 | 1.58 | Why? |
| In Situ Hybridization, Fluorescence | 3 | 2018 | 207 | 1.53 | Why? |
| Acanthamoeba | 2 | 2018 | 36 | 1.42 | Why? |
| Fossils | 2 | 2018 | 32 | 1.41 | Why? |
| Dental Pulp | 3 | 2017 | 48 | 1.35 | Why? |
| Bacterial Proteins | 6 | 2018 | 1318 | 1.30 | Why? |
| Tooth | 2 | 2018 | 42 | 1.06 | Why? |
| Microscopy, Fluorescence | 3 | 2018 | 335 | 1.02 | Why? |
| Coculture Techniques | 3 | 2019 | 258 | 1.02 | Why? |
| Microbial Viability | 4 | 2018 | 406 | 0.90 | Why? |
| Brain Abscess | 3 | 2019 | 50 | 0.89 | Why? |
| Staining and Labeling | 2 | 2018 | 169 | 0.86 | Why? |
| RNA, Ribosomal, 16S | 9 | 2018 | 793 | 0.85 | Why? |
| Phylogeny | 9 | 2018 | 13341 | 0.83 | Why? |
| Sputum | 6 | 2018 | 1720 | 0.82 | Why? |
| Extensively Drug-Resistant Tuberculosis | 2 | 2017 | 87 | 0.80 | Why? |
| Bacteremia | 3 | 2018 | 1372 | 0.79 | Why? |
| Microbiota | 5 | 2019 | 1240 | 0.78 | Why? |
| Planarians | 1 | 2018 | 5 | 0.78 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 393 | 0.78 | Why? |
| Genome, Bacterial | 4 | 2019 | 446 | 0.77 | Why? |
| Staphylococcus | 2 | 2018 | 77 | 0.76 | Why? |
| Alphaproteobacteria | 1 | 2018 | 6 | 0.75 | Why? |
| Biguanides | 1 | 2018 | 7 | 0.74 | Why? |
| Blotting, Western | 1 | 2021 | 863 | 0.73 | Why? |
| Acanthamoeba Keratitis | 1 | 2018 | 15 | 0.73 | Why? |
| Genotyping Techniques | 1 | 2021 | 360 | 0.72 | Why? |
| Epididymitis | 1 | 2018 | 39 | 0.71 | Why? |
| Plant Roots | 1 | 2018 | 108 | 0.71 | Why? |
| Mycobacterium kansasii | 1 | 2017 | 14 | 0.70 | Why? |
| Bacterial Translocation | 1 | 2017 | 39 | 0.70 | Why? |
| Mycobacterium Infections, Nontuberculous | 2 | 2018 | 167 | 0.70 | Why? |
| Mycobacterium phlei | 1 | 2017 | 1 | 0.70 | Why? |
| Drug Resistance, Multiple, Bacterial | 4 | 2018 | 1115 | 0.70 | Why? |
| Acanthamoeba castellanii | 1 | 2018 | 39 | 0.69 | Why? |
| Paleontology | 1 | 2017 | 12 | 0.69 | Why? |
| Genes, Bacterial | 5 | 2018 | 207 | 0.67 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2018 | 239 | 0.67 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.67 | Why? |
| Topography, Medical | 1 | 2017 | 45 | 0.67 | Why? |
| Drug Tolerance | 1 | 2017 | 100 | 0.65 | Why? |
| Soil Microbiology | 1 | 2017 | 63 | 0.65 | Why? |
| Intestines | 2 | 2013 | 817 | 0.64 | Why? |
| Bacterial Load | 2 | 2017 | 179 | 0.64 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2018 | 155 | 0.59 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.58 | Why? |
| Regeneration | 1 | 2018 | 429 | 0.58 | Why? |
| Environmental Microbiology | 2 | 2017 | 575 | 0.57 | Why? |
| Periodontitis | 2 | 2017 | 171 | 0.56 | Why? |
| Carbon | 1 | 2017 | 269 | 0.56 | Why? |
| Methylene Blue | 1 | 2017 | 175 | 0.56 | Why? |
| Hodgkin Disease | 1 | 2017 | 204 | 0.56 | Why? |
| Molecular Biology | 1 | 2017 | 139 | 0.55 | Why? |
| Staphylococcal Infections | 3 | 2018 | 1099 | 0.55 | Why? |
| Tuberculosis | 5 | 2018 | 2895 | 0.53 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.53 | Why? |
| Culture Techniques | 1 | 2013 | 36 | 0.52 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.52 | Why? |
| Disease Reservoirs | 3 | 2018 | 1672 | 0.52 | Why? |
| Microbial Sensitivity Tests | 6 | 2019 | 2886 | 0.51 | Why? |
| Mouth | 1 | 2018 | 622 | 0.50 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.48 | Why? |
| Urinary Bladder Neoplasms | 1 | 2018 | 614 | 0.45 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 2 | 2017 | 800 | 0.45 | Why? |
| DNA | 1 | 2017 | 778 | 0.43 | Why? |
| Metagenome | 1 | 2013 | 268 | 0.43 | Why? |
| France | 13 | 2021 | 12074 | 0.42 | Why? |
| Plants | 1 | 2013 | 247 | 0.41 | Why? |
| Biodiversity | 2 | 2015 | 546 | 0.41 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.41 | Why? |
| Bacterial Typing Techniques | 5 | 2017 | 273 | 0.41 | Why? |
| Gastrointestinal Tract | 2 | 2019 | 1113 | 0.40 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.40 | Why? |
| Fungi | 1 | 2013 | 471 | 0.39 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.38 | Why? |
| Ships | 1 | 2017 | 1046 | 0.37 | Why? |
| Feces | 3 | 2018 | 4235 | 0.36 | Why? |
| Halomonas | 1 | 2007 | 3 | 0.36 | Why? |
| Sequence Analysis, DNA | 6 | 2018 | 2830 | 0.36 | Why? |
| DNA, Circular | 2 | 2018 | 26 | 0.36 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.35 | Why? |
| Fresh Water | 1 | 2007 | 59 | 0.34 | Why? |
| Clofazimine | 2 | 2017 | 85 | 0.33 | Why? |
| Milk | 2 | 2018 | 158 | 0.32 | Why? |
| Minocycline | 2 | 2017 | 101 | 0.32 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.31 | Why? |
| Nasopharynx | 4 | 2021 | 10224 | 0.31 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.31 | Why? |
| Osteomyelitis | 2 | 2018 | 131 | 0.30 | Why? |
| Humans | 75 | 2021 | 930598 | 0.30 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.30 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.29 | Why? |
| Communicable Diseases | 2 | 2017 | 2148 | 0.29 | Why? |
| Azithromycin | 4 | 2021 | 3943 | 0.29 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.29 | Why? |
| Hydroxychloroquine | 4 | 2021 | 12447 | 0.28 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.27 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2018 | 11367 | 0.27 | Why? |
| History, 17th Century | 2 | 2018 | 172 | 0.26 | Why? |
| Disease Outbreaks | 4 | 2018 | 27595 | 0.25 | Why? |
| Trench Fever | 2 | 2005 | 11 | 0.25 | Why? |
| Polymerase Chain Reaction | 7 | 2020 | 6740 | 0.24 | Why? |
| Animals | 18 | 2018 | 78931 | 0.24 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2007 | 398 | 0.23 | Why? |
| Lymph Nodes | 3 | 2018 | 1060 | 0.23 | Why? |
| Anti-Bacterial Agents | 5 | 2018 | 10083 | 0.23 | Why? |
| Occupational Diseases | 1 | 2017 | 2787 | 0.23 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.22 | Why? |
| Rifampin | 3 | 2018 | 276 | 0.22 | Why? |
| Automation, Laboratory | 2 | 2021 | 536 | 0.21 | Why? |
| Pediculus | 2 | 2018 | 35 | 0.21 | Why? |
| Euryarchaeota | 1 | 2019 | 1 | 0.20 | Why? |
| Epidemics | 2 | 2018 | 6407 | 0.20 | Why? |
| Borrelia Infections | 1 | 2019 | 12 | 0.20 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.20 | Why? |
| Mycolic Acids | 1 | 2018 | 6 | 0.19 | Why? |
| Leptospira interrogans | 1 | 2018 | 9 | 0.19 | Why? |
| Heat-Shock Response | 1 | 2018 | 47 | 0.19 | Why? |
| Peri-Implantitis | 1 | 2018 | 26 | 0.19 | Why? |
| Male | 31 | 2021 | 367725 | 0.19 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.19 | Why? |
| Evolution, Molecular | 2 | 2018 | 3691 | 0.19 | Why? |
| Mycobacterium avium Complex | 1 | 2018 | 61 | 0.19 | Why? |
| Administration, Intravesical | 1 | 2018 | 94 | 0.18 | Why? |
| Mycobacterium avium-intracellulare Infection | 1 | 2018 | 59 | 0.18 | Why? |
| Acclimatization | 1 | 2018 | 69 | 0.18 | Why? |
| Porphyromonas endodontalis | 1 | 2017 | 3 | 0.18 | Why? |
| Streptococcus intermedius | 1 | 2017 | 3 | 0.18 | Why? |
| DNA, Ribosomal | 1 | 2018 | 112 | 0.18 | Why? |
| Aggregatibacter actinomycetemcomitans | 1 | 2017 | 8 | 0.18 | Why? |
| DNA, Archaeal | 1 | 2017 | 7 | 0.18 | Why? |
| Djibouti | 1 | 2017 | 12 | 0.18 | Why? |
| Paleopathology | 1 | 2017 | 3 | 0.18 | Why? |
| Sulfadiazine | 1 | 2017 | 8 | 0.18 | Why? |
| Pasteurellaceae Infections | 1 | 2017 | 9 | 0.18 | Why? |
| Chloramphenicol | 1 | 2017 | 10 | 0.18 | Why? |
| Mesentery | 1 | 2017 | 43 | 0.18 | Why? |
| Corynebacterium Infections | 1 | 2018 | 26 | 0.18 | Why? |
| Isoniazid | 1 | 2018 | 105 | 0.18 | Why? |
| Amoeba | 1 | 2017 | 22 | 0.18 | Why? |
| Travel | 1 | 2017 | 7220 | 0.18 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.18 | Why? |
| Corynebacterium | 1 | 2018 | 47 | 0.18 | Why? |
| Agar | 1 | 2017 | 15 | 0.18 | Why? |
| Cellulase | 1 | 2017 | 8 | 0.18 | Why? |
| Lymphadenitis | 1 | 2018 | 53 | 0.18 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.17 | Why? |
| Foot Bones | 1 | 2017 | 3 | 0.17 | Why? |
| Adult | 24 | 2021 | 244371 | 0.17 | Why? |
| Madagascar | 1 | 2018 | 197 | 0.17 | Why? |
| Coloring Agents | 1 | 2018 | 116 | 0.17 | Why? |
| Mycobacterium smegmatis | 1 | 2017 | 27 | 0.17 | Why? |
| Prophages | 1 | 2017 | 11 | 0.17 | Why? |
| Giant Viruses | 1 | 2017 | 27 | 0.17 | Why? |
| Burial | 1 | 2017 | 40 | 0.17 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.17 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.17 | Why? |
| Cerebrospinal Fluid | 2 | 2017 | 234 | 0.17 | Why? |
| Tuberculosis Vaccines | 1 | 2018 | 89 | 0.17 | Why? |
| Staphylococcus lugdunensis | 1 | 2017 | 14 | 0.17 | Why? |
| Phenothiazines | 1 | 2017 | 50 | 0.17 | Why? |
| Amikacin | 1 | 2017 | 62 | 0.17 | Why? |
| Nucleic Acid Hybridization | 1 | 2017 | 140 | 0.17 | Why? |
| Parasitemia | 1 | 2017 | 88 | 0.17 | Why? |
| Leptospirosis | 1 | 2018 | 103 | 0.17 | Why? |
| Cellulose | 1 | 2017 | 106 | 0.16 | Why? |
| Keratitis | 1 | 2018 | 102 | 0.16 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.16 | Why? |
| Plasmodium | 1 | 2017 | 74 | 0.16 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.16 | Why? |
| Benzamidines | 1 | 2018 | 206 | 0.16 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.16 | Why? |
| Abscess | 1 | 2019 | 234 | 0.16 | Why? |
| Clarithromycin | 1 | 2017 | 112 | 0.16 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 449 | 0.16 | Why? |
| Bacteria | 2 | 2017 | 1897 | 0.16 | Why? |
| Female | 31 | 2021 | 380317 | 0.16 | Why? |
| Fatigue Syndrome, Chronic | 1 | 2019 | 160 | 0.15 | Why? |
| Disease Models, Animal | 4 | 2017 | 10998 | 0.15 | Why? |
| Software | 2 | 2018 | 2501 | 0.15 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.15 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.15 | Why? |
| Drug Therapy, Combination | 5 | 2021 | 7268 | 0.15 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| RNA Interference | 1 | 2018 | 534 | 0.15 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.15 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.14 | Why? |
| Africa, Northern | 1 | 2017 | 539 | 0.14 | Why? |
| Meningitis | 1 | 2017 | 163 | 0.14 | Why? |
| Species Specificity | 2 | 2017 | 1356 | 0.14 | Why? |
| Molecular Sequence Annotation | 1 | 2017 | 478 | 0.14 | Why? |
| Fluorescent Dyes | 1 | 2018 | 536 | 0.14 | Why? |
| Molecular Sequence Data | 4 | 2013 | 3198 | 0.14 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.13 | Why? |
| Endocarditis | 1 | 2019 | 368 | 0.13 | Why? |
| Zoonoses | 2 | 2018 | 3034 | 0.13 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.13 | Why? |
| Occupational Health Services | 1 | 2017 | 219 | 0.13 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2017 | 323 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.13 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.13 | Why? |
| Urinary Tract Infections | 1 | 2019 | 534 | 0.13 | Why? |
| Dogs | 3 | 2018 | 2529 | 0.13 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.13 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.12 | Why? |
| Senegal | 1 | 2013 | 283 | 0.12 | Why? |
| Tropheryma | 1 | 2012 | 28 | 0.12 | Why? |
| Bartonella quintana | 2 | 2005 | 27 | 0.12 | Why? |
| Metagenomics | 1 | 2018 | 823 | 0.12 | Why? |
| Whipple Disease | 1 | 2012 | 38 | 0.12 | Why? |
| Cat Diseases | 1 | 2018 | 539 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2019 | 1153 | 0.11 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.11 | Why? |
| Dog Diseases | 1 | 2018 | 745 | 0.11 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
| Eye Infections, Bacterial | 1 | 2012 | 86 | 0.11 | Why? |
| Mice | 4 | 2017 | 21357 | 0.11 | Why? |
| Rats | 1 | 2018 | 2764 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.10 | Why? |
| Aged | 16 | 2021 | 215776 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.10 | Why? |
| Base Sequence | 3 | 2013 | 3581 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Statistics as Topic | 1 | 2012 | 370 | 0.10 | Why? |
| Borrelia | 1 | 2009 | 39 | 0.10 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 1458 | 0.10 | Why? |
| Africa | 1 | 2018 | 2986 | 0.10 | Why? |
| Camelus | 1 | 2018 | 1425 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| Mice, Inbred BALB C | 2 | 2017 | 5814 | 0.10 | Why? |
| Infant, Newborn | 3 | 2017 | 23105 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2020 | 88759 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.09 | Why? |
| Anti-Infective Agents | 2 | 2017 | 1766 | 0.09 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.09 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Homeless Persons | 1 | 2019 | 1171 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Colony Count, Microbial | 2 | 2018 | 177 | 0.08 | Why? |
| History, 15th Century | 1 | 2007 | 73 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| History, 16th Century | 1 | 2007 | 104 | 0.08 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.08 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.08 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.08 | Why? |
| Rickettsia prowazekii | 1 | 2005 | 3 | 0.08 | Why? |
| History, Ancient | 1 | 2007 | 141 | 0.08 | Why? |
| History, Medieval | 1 | 2007 | 131 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.08 | Why? |
| Typhus, Epidemic Louse-Borne | 1 | 2005 | 17 | 0.08 | Why? |
| Proteome | 1 | 2017 | 1812 | 0.08 | Why? |
| History, 18th Century | 1 | 2007 | 192 | 0.08 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.08 | Why? |
| Lice Infestations | 1 | 2005 | 39 | 0.08 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.08 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.08 | Why? |
| Tunisia | 1 | 2007 | 543 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| Cross Infection | 1 | 2007 | 8675 | 0.07 | Why? |
| Computational Biology | 2 | 2018 | 4514 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.07 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.07 | Why? |
| Heart Transplantation | 1 | 2014 | 1293 | 0.07 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Child, Preschool | 3 | 2017 | 36283 | 0.06 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Point-of-Care Testing | 1 | 2017 | 2782 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Respiratory System | 1 | 2014 | 3213 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Intensive Care Units, Neonatal | 1 | 2007 | 749 | 0.06 | Why? |
| Child | 4 | 2017 | 70012 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.06 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.05 | Why? |
| Coinfection | 2 | 2018 | 6820 | 0.05 | Why? |
| Cats | 2 | 2018 | 1890 | 0.05 | Why? |
| Mass Spectrometry | 2 | 2017 | 1165 | 0.05 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Tuberculosis, Cutaneous | 1 | 1999 | 14 | 0.05 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 2984 | 0.05 | Why? |
| Bacteria, Anaerobic | 1 | 2019 | 20 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Tuberculosis, Miliary | 1 | 1999 | 66 | 0.05 | Why? |
| Renal Dialysis | 1 | 1996 | 4358 | 0.05 | Why? |
| Francisella tularensis | 1 | 2018 | 28 | 0.05 | Why? |
| Bartonella henselae | 1 | 2018 | 28 | 0.05 | Why? |
| Muscles | 1 | 2019 | 152 | 0.05 | Why? |
| DNA Restriction Enzymes | 1 | 2017 | 6 | 0.05 | Why? |
| Equipment Contamination | 1 | 2007 | 1308 | 0.04 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.04 | Why? |
| 3T3-L1 Cells | 1 | 2017 | 29 | 0.04 | Why? |
| Algeria | 1 | 2018 | 185 | 0.04 | Why? |
| Methane | 1 | 2017 | 26 | 0.04 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.04 | Why? |
| Immunocompromised Host | 1 | 2014 | 5150 | 0.04 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.04 | Why? |
| Urinalysis | 1 | 2019 | 218 | 0.04 | Why? |
| Sequence Homology | 1 | 2018 | 448 | 0.04 | Why? |
| Plasma | 1 | 2007 | 1809 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Chromatography | 1 | 2017 | 112 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Adipocytes | 1 | 2017 | 173 | 0.04 | Why? |
| Cytodiagnosis | 1 | 2017 | 104 | 0.04 | Why? |
| Polynesia | 1 | 2015 | 62 | 0.04 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.04 | Why? |
| Military Personnel | 1 | 2005 | 1097 | 0.04 | Why? |
| Infant | 2 | 2017 | 30274 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2017 | 800 | 0.03 | Why? |
| Animals, Domestic | 1 | 1996 | 272 | 0.03 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Geographic Mapping | 1 | 2015 | 247 | 0.03 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| Sjogren's Syndrome | 1 | 1996 | 284 | 0.03 | Why? |
| Boutonneuse Fever | 1 | 1992 | 21 | 0.03 | Why? |
| Dysbiosis | 1 | 2019 | 685 | 0.03 | Why? |
| Bone Marrow | 1 | 1996 | 492 | 0.03 | Why? |
| Tetracycline | 1 | 2012 | 33 | 0.03 | Why? |
| Antibodies, Bacterial | 1 | 1996 | 510 | 0.03 | Why? |
| Obesity | 1 | 2013 | 7388 | 0.03 | Why? |
| RNA, Bacterial | 1 | 2012 | 116 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| DNA Primers | 1 | 1996 | 1170 | 0.03 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2012 | 170 | 0.03 | Why? |
| Vitreous Body | 1 | 2012 | 161 | 0.03 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Borrelia burgdorferi Group | 1 | 2009 | 12 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.03 | Why? |
| DNA, Ribosomal Spacer | 1 | 2009 | 49 | 0.03 | Why? |
| Influenza, Human | 1 | 2014 | 10779 | 0.02 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2009 | 60 | 0.02 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.02 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Serotyping | 1 | 2009 | 154 | 0.02 | Why? |
| Molecular Epidemiology | 1 | 2015 | 1638 | 0.02 | Why? |
| Drug Resistance | 1 | 2012 | 395 | 0.02 | Why? |
| Biomarkers | 1 | 2012 | 23361 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Ixodes | 1 | 2009 | 58 | 0.02 | Why? |
| Uveitis | 1 | 2012 | 233 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Fluorescein Angiography | 1 | 2012 | 426 | 0.02 | Why? |
| Antigens, Surface | 1 | 2009 | 181 | 0.02 | Why? |
| Bacterial Vaccines | 1 | 2009 | 139 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Lyme Disease | 1 | 2009 | 102 | 0.02 | Why? |
| Lipoproteins | 1 | 2009 | 240 | 0.02 | Why? |
| Rodentia | 1 | 2009 | 235 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Paleodontology | 1 | 2005 | 3 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Climate | 1 | 1992 | 557 | 0.02 | Why? |
| Birds | 1 | 2009 | 412 | 0.02 | Why? |
| Antigens, Bacterial | 1 | 2009 | 330 | 0.02 | Why? |
| Lithuania | 1 | 2005 | 92 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Pregnancy | 1 | 2007 | 23879 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2012 | 48226 | 0.02 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.02 | Why? |
| History, 19th Century | 1 | 2005 | 384 | 0.02 | Why? |
| Hepatitis C | 1 | 2014 | 1514 | 0.02 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.01 | Why? |
| Enzyme Inhibitors | 1 | 2012 | 1881 | 0.01 | Why? |
| Genetic Variation | 1 | 2015 | 3919 | 0.01 | Why? |
| Glucocorticoids | 1 | 2012 | 4431 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 13720 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2019 | 23402 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Rural Health | 1 | 1992 | 243 | 0.01 | Why? |
| Incidence | 1 | 1992 | 25622 | 0.00 | Why? |